Patient Guide: Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 202 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04960709
Status: ACTIVE_NOT_RECRUITING
Condition: Muscle Invasive Bladder Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 202 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Orange, California
  • Santa Monica, California
  • New Haven, Connecticut
  • • And 199 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily